Rucaparib,Nivolumab
BMS,clovis oncology
['rucaparib', 'brca']
athena phase 3 trial 1st line maintenance rucaparib pfs benefit by subgroup #asco22 brcamut and hrd (defined by loh )still driving best responses but all patients with platinum response should still be offered/discussed parp maintenance confirming asco guidelines 
Medical Oncologist at @BCcancer Vancouver specialist in GYN Cancers, Assoc Prof @ubc, Brit abroad,??, parent of 3 kiddos, views my own